Viking Therapeutics, Inc.
SEC CIK 1607678 · VKTX · last insider filing 2026-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Foehr Matthew W | Director | filed 2015 - 2026 |
| Singleton J Matthew | Director | filed 2015 - 2026 |
| Rowland Charles A Jr | Director | filed 2017 - 2026 |
| Macartney Lawson | Director | filed 2015 - 2026 |
| Lian Brian | Director · President & CEO | filed 2015 - 2026 |
| Rouan Sarah Kathryn | Director | filed 2019 - 2026 |
| Webster Stephen W | Director | filed 2015 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Chen Hubert C | Chief Medical Officer | filed 2026 - 2026 |
| Aubuchon Neil William | Chief Commercial Officer | filed 2026 - 2026 |
| Zante Greg | Chief Financial Officer | filed 2021 - 2026 |
| Mancini Marianna | Chief Operating Officer | filed 2021 - 2026 |
| Morneau Michael | VP, Finance and Administration | filed 2015 - 2021 |
| Masamune Hiroko | Chief Development Officer | filed 2018 - 2019 |
| Hanley Rochelle | Chief Medical Officer | filed 2015 - 2016 |
| Dinerman Michael | Chief Operating Officer | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.